FOIADELLI, THOMAS
 Distribuzione geografica
Continente #
NA - Nord America 520
EU - Europa 282
AS - Asia 174
SA - Sud America 10
AF - Africa 4
Totale 990
Nazione #
US - Stati Uniti d'America 512
IE - Irlanda 150
CN - Cina 104
SG - Singapore 44
IT - Italia 43
FI - Finlandia 31
DE - Germania 28
IN - India 12
SE - Svezia 11
CA - Canada 8
BE - Belgio 5
EG - Egitto 4
GB - Regno Unito 4
KZ - Kazakistan 4
RU - Federazione Russa 4
BR - Brasile 3
CO - Colombia 3
KR - Corea 3
NL - Olanda 3
AR - Argentina 2
CL - Cile 2
CZ - Repubblica Ceca 2
IR - Iran 2
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
VN - Vietnam 1
Totale 990
Città #
Dublin 150
Chandler 131
Ashburn 58
Singapore 35
Boardman 33
Helsinki 28
Beijing 24
Lawrence 22
Medford 22
Princeton 22
Wilmington 16
Shanghai 15
New York 10
Ann Arbor 7
Los Angeles 7
Nanjing 7
Pune 7
Toronto 7
Jacksonville 6
Munich 6
Norwalk 6
Pavia 6
Redwood City 6
Washington 6
Brussels 5
Hangzhou 5
Hebei 5
Milan 5
Almaty 4
Cagliari 4
Cairo 4
Falls Church 4
Frankfurt am Main 4
Trebaseleghe 4
Chengdu 3
Dallas 3
Dearborn 3
Guangzhou 3
Medellín 3
Nanchang 3
Tianjin 3
Wuhan 3
Brno 2
Cosenza 2
General Roca 2
Genzano di Roma 2
Kunming 2
Nuremberg 2
Pittsburgh 2
Seattle 2
Seoul 2
Vleuten 2
Woodbridge 2
Amsterdam 1
Ashdod 1
Berlin 1
Bhubaneswar 1
Budapest 1
Cambridge 1
Changsha 1
Chapel Hill 1
Dalian 1
Dubino 1
Espoo 1
Esslingen am Neckar 1
Fairfield 1
Falkenstein 1
Foshan 1
Fushun 1
Hanoi 1
Jiaxing 1
Jinan 1
London 1
Markham 1
Mianyang 1
Moscow 1
Ningbo 1
Nizhniy Novgorod 1
Phnom Penh 1
San Francisco 1
San Giovanni Bianco 1
Sandston 1
Shenyang 1
Sindelfingen 1
St Louis 1
Stockholm 1
Swansea 1
São José dos Campos 1
São Paulo 1
Taizhou 1
Tokyo 1
Volgograd 1
Wood Green 1
Wuxi 1
Xingtai 1
Xinyi 1
Yekaterinburg 1
Yiwu 1
Zhengzhou 1
Totale 773
Nome #
The clinical spectrum of Myelin Oligodendrocyte Glycoprotein (MOG)-associated disorders in children 71
Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis 53
Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges 53
Omalizumab in children. 51
Gene therapies for high-grade gliomas: From the bench to the bedside 51
Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination 45
Absence of lingual frenulum in children with Ehlers-Danlos Syndrome: a retrospective study of forty cases and literature review of a twenty years long debate 43
SARS-CoV-2 infection in pediatric population 43
Potential roads for reaching the summit: An overview on target therapies for high-grade gliomas 42
Melkersson–rosenthal syndrome in childhood: Report of three paediatric cases and a review of the literature 40
Advanced pharmacological therapies for neurofibromatosis type 1-related tumors 40
Immunomodulation in pediatric asthma 39
Abdominal pain as first manifestation of lyme neuroborreliosis in children, case report and review of literature 39
Biologics in Children with Allergic Diseases 38
Innovative therapies for malignant brain tumors: The road to a tailored cure 38
Cough Remedies for Children and Adolescents: Current and Future Perspectives 37
The impact of stem cells in neuro-oncology: Applications, evidence, limitations and challenges 35
West-Nile virus encephalitis in an immunocompetent pediatric patient: successful recovery 30
Pai syndrome: a review 28
Clinical variability in children with dolichoarteriopathies of the internal carotid artery 27
Subtraction Ictal SPECT coregistered to MRI (SISCOM) as a guide in localizing childhood epilepsy 26
Human Herpes Virus 7-related encephalopathy in children 24
West-Nile virus encephalitis in an immunocompetent pediatric patient: successful recovery 22
Targeting the medulloblastoma: A molecular-based approach 21
Pediatric traumatic brain injury: a new relation between outcome and neutrophil-to-lymphocite ratio 20
Early Developmental Intervention and Enriched Environment in CDKL5 Developmental and Epileptic Encephalopathy 17
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis 16
Acneiform rash as a side effect of selumetinib in a child with neurofibromatosis type 1 treated for inoperable plexiform neurofibromas: Good results with doxycycline 15
Expanding the Spectrum of Autosomal Dominant ATP6V1A-Related Disease: Case Report and Literature Review 10
KIRREL3-related disorders: a case report confirming the radiological features and expanding the clinical spectrum to a less severe phenotype 5
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study 5
Totale 1.024
Categoria #
all - tutte 6.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 0 0 0 0 0 0 1 1 7 2 5 0
2020/202161 2 1 22 3 4 6 6 7 3 2 2 3
2021/2022125 0 0 8 0 5 8 3 4 9 5 15 68
2022/2023378 36 40 5 24 24 35 0 18 180 2 12 2
2023/2024244 16 37 11 17 16 57 14 21 0 15 27 13
2024/2025154 28 35 15 21 18 37 0 0 0 0 0 0
Totale 1.024